| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 2″-O-没食子酰基杨梅苷; 2''-O-Galloylmyricitrin | CFN95046 | 56939-52-7 | C28H24O16 = 616.5 | 5mg | QQ客服：2056216494 |
| Betmidin; Betmidin | CFN95047 | 35589-22-1 | C20H18O12 = 450.4 | 5mg | QQ客服：2159513211 |
| 3″-O-没食子酰基槲皮苷; 3''-Galloylquercitrin | CFN95048 | 503446-90-0 | C28H24O15 = 600.5 | 5mg | QQ客服：2056216494 |
| 4',5,6,7-四甲氧基黄酮; 4',5,6,7-Tetramethoxyflavone | CFN91034 | 1168-42-9 | C19H18O6 = 342.4 | 5mg | QQ客服：1413575084 |
| 葛花苷; Kakkalide | CFN95052 | 58274-56-9 | C28H32O15 = 608.6 | 10mg | QQ客服：1413575084 |
| 忍冬苷; Lonicerin | CFN95055 | 25694-72-8 | C27H30O15 = 594.5 | 10mg | QQ客服：215959384 |
| 3''-O-没食子酰基杨梅苷; 3''-O-Galloylmyricitrin | CFN95057 | 143202-36-2 | C28H24O16 = 616.5 | 5mg | QQ客服：1457312923 |
| 甘草瑞酮; Glicoricone | CFN95063 | 161099-37-2 | C21H20O6 = 368.4 | 5mg | QQ客服：1457312923 |
| 粗毛甘草素C; Glyasperin C | CFN95065 | 142474-53-1 | C21H24O5 = 356.4 | 5mg | QQ客服：3257982914 |
| 甘草宁N; Gancaonin N | CFN95066 | 129145-52-4 | C21H20O6 = 368.4 | 5mg | QQ客服：2159513211 |
| 4''-甲氧基大豆苷; 4''-methyloxy-Daidzin | CFN93005 | 1195968-02-5 | C22H22O9 = 430.40 | 5mg | QQ客服：2056216494 |
| 4''-甲氧基染料木苷; 4''-methyloxy-Genistin | CFN93006 | 950910-16-4 | C22H22O10 = 446.40 | 5mg | QQ客服：215959384 |
| 红景天素; Rhodiosin | CFN93017 | 86831-54-1 | C27H30O16 = 610.52 | 10mg | QQ客服：2056216494 |
| 5-甲基-7-甲氧基异黄酮; 5-Methyl-7-methoxyisoflavone | CFN93022 | 82517-12-2 | C17H14O3 = 266.29 | 5mg | QQ客服：2056216494 |
| 异鼠李素 3-O-半乳糖苷; Isorhamnetin 3-O-galactoside | CFN93036 | 6743-92-6 | C22H22O12 = 478.40 | 5mg | QQ客服：1457312923 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)